These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 35481431

  • 41. Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.
    Daas A, Milne C.
    Pharmeuropa Bio; 2004 Dec; 2004(1):17-22. PubMed ID: 15659282
    [Abstract] [Full Text] [Related]

  • 42. Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.
    Morgeaux S, Bornstein N, Mourton-Gilles C, Chagnaud P, Charbonneau J, Maurin J, Daas A, Variot P, Behr-Gross ME.
    Pharmeur Bio Sci Notes; 2020 Dec; 2020():141-160. PubMed ID: 32788037
    [Abstract] [Full Text] [Related]

  • 43. Collaborative study for the establishment of Ph. Eur. Human albumin (molecular size) Biological Reference Preparation batches 1, 2 and 3.
    Sinitskaya N, Regourd E, Wierer M, Behr-Gross ME, Lièvre V.
    Pharmeur Bio Sci Notes; 2021 Dec; 2021():184-198. PubMed ID: 34913434
    [Abstract] [Full Text] [Related]

  • 44. Collaborative study to establish a new biological reference preparation for prekallikrein activator.
    Longstaff C, Behr-Gross ME, Daas A, Lackner F.
    Pharmeuropa Bio; 2005 Sep; 2005(1):1-12. PubMed ID: 16336933
    [Abstract] [Full Text] [Related]

  • 45. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique.
    Nübling CM, Daas A, Buchheit KH.
    Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261
    [Abstract] [Full Text] [Related]

  • 46. Calibration of Ph. Eur. BRP batch 4 for oral poliomyelitis vaccine (OPV).
    Fiore L, De Dominicis A, Daas A, Costanzo A.
    Pharmeur Bio Sci Notes; 2014 Jan; 2014():18-38. PubMed ID: 25655241
    [Abstract] [Full Text] [Related]

  • 47. Collaborative study for the establishment of Infliximab Biological Reference Preparation Batch 1.
    Wadhwa M, Rigsby P, Behr-Gross ME.
    Pharmeur Bio Sci Notes; 2020 Jan; 2020():49-52. PubMed ID: 32459170
    [Abstract] [Full Text] [Related]

  • 48. Collaborative study to establish human immunoglobulin BRP batch 3 and human immunoglobulin (molecular size) BRP batch 1.
    Sandberg E, Daas A, Behr-Gross ME, European Directorate for the Quality of Medicines (EDQM).
    Pharmeuropa Bio; 2006 Nov; 2006(1):37-48. PubMed ID: 17270130
    [Abstract] [Full Text] [Related]

  • 49. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
    Stalder J, Costanzo A, Daas A, Rautmann G, Buchheit KH.
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
    [Abstract] [Full Text] [Related]

  • 50. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed.
    Sesardic D, Winsnes R, Rigsby P, Tierney R, Gaines-Das R.
    Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430
    [Abstract] [Full Text] [Related]

  • 51. Collaborative study for the establishment of Human immunoglobulin (molecular size) BRP replacement batches 4, 5 and 6.
    Jouette S, Regourd E.
    Pharmeur Bio Sci Notes; 2024 Mar; 2024():90-105. PubMed ID: 38967620
    [Abstract] [Full Text] [Related]

  • 52. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D, Winsnes R, Rigsby P, Gaines-Das R.
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [Abstract] [Full Text] [Related]

  • 53. Collaborative study for the establishment of the Ph. Eur. Hepatitis E virus RNA for NAT testing biological reference preparation batch 1.
    Baylis SA, Terao E, Blümel J, Hanschmann KO.
    Pharmeur Bio Sci Notes; 2017 Aug; 2017():12-28. PubMed ID: 28279253
    [Abstract] [Full Text] [Related]

  • 54. Establishment of Ph. Eur. Hepatitis C Virus RNA for NAT testing BRP batch 2.
    Pisani G, Le Tallec D, Costanzo A.
    Pharmeur Bio Sci Notes; 2023 Aug; 2023():15-41. PubMed ID: 37347249
    [Abstract] [Full Text] [Related]

  • 55. Establishment of the human albumin for electrophoresis Ph. Eur. BRP batches 3 and 4.
    Behr-Gross ME, Daas A, Eulig-Wien A, Christians S.
    Pharmeur Bio Sci Notes; 2015 Aug; 2015():181-9. PubMed ID: 26830166
    [Abstract] [Full Text] [Related]

  • 56. Collaborative study for the establishment of erythropoietin BRP batch 2.
    Behr-Gross ME, Daas A, Bristow AF.
    Pharmeuropa Bio; 2004 Dec; 2004(1):23-33. PubMed ID: 15659283
    [Abstract] [Full Text] [Related]

  • 57. Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2.
    Stickings P, Tierney R, Hockley J, Rigsby P, Terao E.
    Pharmeur Bio Sci Notes; 2024 Dec; 2024():1-11. PubMed ID: 38252512
    [Abstract] [Full Text] [Related]

  • 58. Establishment of hepatitis A vaccine (inactivated, non-adsorbed) BRP batches 2 and 3.
    Morgeaux S, Manniam I, Variot P, Buchheit KH, Daas A, Wierer M, Costanzo A.
    Pharmeur Bio Sci Notes; 2015 Dec; 2015():118-30. PubMed ID: 26830162
    [Abstract] [Full Text] [Related]

  • 59. Establishment of Pertussis toxin BRP batch 2 for CHO clustering assay.
    Wall M, Costanzo A, Le Tallec D, Isbrucker R.
    Pharmeur Bio Sci Notes; 2021 Dec; 2021():69-87. PubMed ID: 33934749
    [Abstract] [Full Text] [Related]

  • 60. Collaborative study to establish the Low-molecular-mass heparin for assay--European Pharmacopoeia Biological Reference Preparation.
    Gray E, Rigsby P, Behr-Gross ME.
    Pharmeuropa Bio; 2004 Dec; 2004(1):59-76. PubMed ID: 15659286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.